Genomic Health, Inc. (GHDX) Tops Q2 EPS by 6c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
FWDI, GO, BATL, More
Financial Fact:
Research and development: 46.4M
Today's EPS Names:
FWDI, GO, BATL, More
Join SI Premium – FREE
Genomic Health, Inc. (NASDAQ: GHDX) reported Q2 EPS of $0.08, $0.06 better than the analyst estimate of $0.02. Revenue for the quarter came in at $50.8 million versus the consensus estimate of $50.87 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Octave Intelligence plc (OCTV) Tops Q2 EPS by 4c ; Offers Guidance
- Century Therapeutics, Inc. (IPSC) Misses Q2 EPS by 6c
- Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
